Mary Ruisi

Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis

Sandra P. D’Angelo, James Larkin, Jeffrey A. Sosman et al. · Journal of Clinical Oncology · 2017 · 617 citations · Full text

Mucosal Melanoma, Purpose Mucosal Melanoma, Medicine +13

Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study

Fabrice Barlési, Johan Vansteenkiste, David R. Spigel et al. · The Lancet Oncology · 2018 · 394 citations

Medicine, Metronomic Therapy, Clinical Trials +9

Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial

Jeffrey S. Weber, Geoff Gibney, Ryan J. Sullivan et al. · The Lancet Oncology · 2016 · 329 citations · Full text

Medicine, Melanoma, Clinical Trials +8

VE303, a Defined Bacterial Consortium, for Prevention of Recurrent <i>Clostridioides difficile</i> Infection

Thomas Louie, Yoav Golan, Sahil Khanna et al. · JAMA · 2023 · 161 citations · Full text

Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia

Sarah Barsam, Bethan Psaila, Marc Forestier et al. · Blood · 2011 · 153 citations · Full text